Target Audience

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, nurses, nurse practitioners, and registered dietitians interested in lipid management.

Learning Objectives

At the conclusion of this activity, participants should be able to:

• Discuss epidemiologic and statistical evidence related to cardiovascular disease risk and the translation of current research into effective treatment approaches for CVD prevention.
• Compare and contrast the effectiveness of available risk assessment instruments and markers in predicting CV risk in the intermediate risk population.
• Assess the impact of diet, weight reduction, exercise and behavior modifications on cardiovascular risk factors and encourage such changes in patient behavior.
• Implement aggressive therapies for the management of dyslipidemia to ensure that at-risk patients meet all of their target lipid levels.
• Clinically manage challenging cases, including patients experiencing statin intolerance or adverse events associated with lipid-altering drugs.
• Apply effective strategies to encourage patient adherence to therapy.
• Incorporate appropriate risk assessment and treatment strategies in special risk populations.

The Evaluation and Treatment of the
Intermediate Risk CHD Patient
August 27 - 29, 2010

An expert faculty of thought leaders will gather to share their insights and enhance your ability to:

• Explore the spectrum of established and novel biomarkers and other risk assessment tools for CV risk detection
• Evaluate the impact of diet, weight reduction, and exercise modifications on cardiovascular risk and risk factors
• Improve your skills in managing challenging cases and expand your knowledge of advanced lipid testing
• Sharpen your risk prediction skills through the use of imaging modalities for further risk stratification
• Review management options and emerging therapies for dyslipidemia and related cardiometabolic conditions for special risk populations

CME credit provided by the National Lipid Association

Physicians
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Lipid Association designates this educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare

Pharmacists
AKH Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc. approves this application-based activity for 11.5 contact hours (1.15 CEUs).
UAN 0077-9999-10-026-L01-P.

Nurses
AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center´s Commission on Accreditation (ANCC-COA).
AKH Inc. designates this educational activity for 11.5 contact hours (1.15 CEUs). Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.

Dietitians
AKH Inc. is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 11.5 continuing professional education units (CPEUs) for completion of this program/material. Provider #AN008. The focus of this activity is rated Level 2. Learners may submit evaluations of program/materials quality to the CDR at www.cdrnet.org.

Criteria for Success
Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme.

Faculty Disclosure Statement
The National Lipid Association and AKH Inc. adhere to ACCME essential areas and policies, and ACPE and ANCC standards regarding industry support of CME/ CE. Disclosure of faculty and commercial relationships, if any, are in the syllabus. Identified conflicts are resolved prior to the certification of the activity. The National Lipid Association and AKH Inc. planners and reviewers have no relevant financial relationships to disclose.

Commercial Support
Full notification of commercial support will be provided in the activity syllabus.